Venus Remedies Limited has informed the Exchange regarding 'Disclosure of information received from promoter group companies regarding merger.'.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies has disclosed that two promoter group companies, Sunev Pharma Solutions Pvt Ltd and Spine Software Systems Pvt Ltd, have approved a Scheme of Amalgamation for the merger of Sunev into Spine, subject to regulatory approvals. Sunev currently holds 17.21% of Venus Remedies' equity share capital, which will transfer to Spine once the scheme takes effect. The company clarified this is an internal promoter group restructuring with no change in control of Venus Remedies, and aggregate promoter group shareholding will remain unchanged. Venus Remedies itself is not a party to the scheme.
Neutral for Venus Remedies shareholders — the merger is between promoter group entities and does not affect the company's business, control, or shareholding pattern. The 17.21% stake simply shifts from one promoter group entity to another within the same group.